162 related articles for article (PubMed ID: 31217017)
21. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ
Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
[TBL] [Abstract][Full Text] [Related]
22. Outcome for children with supratentorial primitive neuroectodermal tumors treated with surgery, radiation, and chemotherapy.
Reddy AT; Janss AJ; Phillips PC; Weiss HL; Packer RJ
Cancer; 2000 May; 88(9):2189-93. PubMed ID: 10813733
[TBL] [Abstract][Full Text] [Related]
23. Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: results of the first UKCCSG/SIOP CNS 9204 trial.
Grundy RG; Wilne SH; Robinson KJ; Ironside JW; Cox T; Chong WK; Michalski A; Campbell RH; Bailey CC; Thorp N; Pizer B; Punt J; Walker DA; Ellison DW; Machin D;
Eur J Cancer; 2010 Jan; 46(1):120-33. PubMed ID: 19818598
[TBL] [Abstract][Full Text] [Related]
24. [Radiotherapy and/or chemotherapy in children with primitive neuroectodermal tumor (PNET) of the pineal region].
Dunst J
Strahlenther Onkol; 1996 Feb; 172(2):108-9. PubMed ID: 8669042
[No Abstract] [Full Text] [Related]
25. Evaluation of intracranial cerebrospinal fluid cytology in staging pediatric medulloblastomas, supratentorial primitive neuroectodermal tumors, and ependymomas.
Terterov S; Krieger MD; Bowen I; McComb JG
J Neurosurg Pediatr; 2010 Aug; 6(2):131-6. PubMed ID: 20672933
[TBL] [Abstract][Full Text] [Related]
26. Curative treatment for central nervous system medulloepithelioma despite residual disease after resection. Report of two cases treated according to the GPHO Protocol HIT 2000 and review of the literature.
Müller K; Zwiener I; Welker H; Maass E; Bongartz R; Berthold F; Pietsch T; Warmuth-Metz M; von Bueren A; Rutkowski S
Strahlenther Onkol; 2011 Nov; 187(11):757-62. PubMed ID: 22037651
[TBL] [Abstract][Full Text] [Related]
27. Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET.
Saran F; Baumert BG; Creak AL; Warrington AP; Ashley S; Traish D; Brada M
Pediatr Blood Cancer; 2008 Mar; 50(3):554-60. PubMed ID: 17941071
[TBL] [Abstract][Full Text] [Related]
28. Primary Ewing's sarcoma/primitive neuroectodermal tumor of the kidney: a clinicopathologic and immunohistochemical analysis of 11 cases.
Jimenez RE; Folpe AL; Lapham RL; Ro JY; O'Shea PA; Weiss SW; Amin MB
Am J Surg Pathol; 2002 Mar; 26(3):320-7. PubMed ID: 11859203
[TBL] [Abstract][Full Text] [Related]
29. Analysis of patients with supratentorial primitive neuro-ectodermal tumours entered into the SIOP/UKCCSG PNET 3 study.
Pizer BL; Weston CL; Robinson KJ; Ellison DW; Ironside J; Saran F; Lashford LS; Tait D; Lucraft H; Walker DA; Bailey CC; Taylor RE
Eur J Cancer; 2006 May; 42(8):1120-8. PubMed ID: 16632346
[TBL] [Abstract][Full Text] [Related]
30. Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study.
Strother D; Ashley D; Kellie SJ; Patel A; Jones-Wallace D; Thompson S; Heideman R; Benaim E; Krance R; Bowman L; Gajjar A
J Clin Oncol; 2001 May; 19(10):2696-704. PubMed ID: 11352962
[TBL] [Abstract][Full Text] [Related]
31. Role of radiotherapy in supratentorial primitive neuroectodermal tumor in young children: results of the German HIT-SKK87 and HIT-SKK92 trials.
Timmermann B; Kortmann RD; Kühl J; Rutkowski S; Meisner C; Pietsch T; Deinlein F; Urban C; Warmuth-Metz M; Bamberg M
J Clin Oncol; 2006 Apr; 24(10):1554-60. PubMed ID: 16575007
[TBL] [Abstract][Full Text] [Related]
32. [Current and future strategies in interdisciplinary treatment of medulloblastomas, supratentorial PNET (primitive neuroectodermal tumors) and intracranial germ cell tumors in childhood].
Kortmann RD; Kühl J; Timmermann B; Calaminus G; Dieckmann K; Wurm R; Sörensen N; Urban C; Göbel U; Bamberg M
Strahlenther Onkol; 2001 Sep; 177(9):447-61. PubMed ID: 11591018
[TBL] [Abstract][Full Text] [Related]
33. Supratentorial primitive neuroectodermal tumors (S-PNET) in children: A prospective experience with adjuvant intensive chemotherapy and hyperfractionated accelerated radiotherapy.
Massimino M; Gandola L; Spreafico F; Luksch R; Collini P; Giangaspero F; Simonetti F; Casanova M; Cefalo G; Pignoli E; Ferrari A; Terenziani M; Podda M; Meazza C; Polastri D; Poggi G; Ravagnani F; Fossati-Bellani F
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1031-7. PubMed ID: 16343801
[TBL] [Abstract][Full Text] [Related]
34. Embryonal tumors in the adult population: implications in therapeutic planning.
Boiardi A; Silvani A; Eoli M; Fariselli L; Zappacosta B; Salmaggi A
Neurol Sci; 2000 Feb; 21(1):23-30. PubMed ID: 10938199
[TBL] [Abstract][Full Text] [Related]
35. Radiotherapy for pediatric central nervous system tumors: a regional cancer centre experience.
Bauman G; Fisher B; Cairney E; Ranger A; Dar AR; Ross J; Stitt L; MacDonald D
J Neurooncol; 2004 Jul; 68(3):285-94. PubMed ID: 15332333
[TBL] [Abstract][Full Text] [Related]
36. Primary Primitive Neuroectodermal Tumor Arising from an Ovarian Mature Cystic Teratoma in a 12-Year-Old Girl: A Case Report.
Jaramillo-Huff A; Bakkar R; McKee JQ; Sokkary N
J Pediatr Adolesc Gynecol; 2017 Aug; 30(4):511-512. PubMed ID: 27919713
[TBL] [Abstract][Full Text] [Related]
37. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
Grier HE; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Miser JS
N Engl J Med; 2003 Feb; 348(8):694-701. PubMed ID: 12594313
[TBL] [Abstract][Full Text] [Related]
38. Radiological features of primitive neuroectodermal tumors in intra-abdominal and retroperitoneal regions: A series of 18 cases.
Yi X; Liu W; Zhang Y; Xiao D; Yin H; Long X; Li L; Zai H; Chen M; Li W; Sun L
PLoS One; 2017; 12(3):e0173536. PubMed ID: 28319177
[TBL] [Abstract][Full Text] [Related]
39. An Analysis of Prognostic Factors in Patients with Ovarian Malignant Germ Cell Tumors Who Are Treated with Fertility-Preserving Surgery.
Yang ZJ; Liu ZC; Wei RJ; Li L
Gynecol Obstet Invest; 2016; 81(1):1-9. PubMed ID: 25967958
[TBL] [Abstract][Full Text] [Related]
40. Patients with non-functional metastatic G2 pancreatic neuroendocrine tumor benefit from palliative surgery: A 20-year single-center retrospective analysis.
You T; Tang H; Xu X; Ying H; Sun Z; Cheng Y; Bai C
J Neuroendocrinol; 2022 Dec; 34(12):e13211. PubMed ID: 36373196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
